Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Antiviral Drug Synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced patent CN101351438A details a safer, scalable route to Tamiflu intermediates using transketalization, eliminating toxic reagents and solid isolations for cost-effective manufacturing.
Patent CN114773309A details a high-yield synthesis of Hepatitis C intermediates using Lewis acid catalysis, offering significant cost reduction and supply chain reliability for API manufacturers.
Patent CN102719378A reveals high-purity (-)-gamma-lactam production via Delftia sp., offering cost-effective API manufacturing solutions.
Patent CN114702471A details a green air-oxidation method for caronic anhydride, replacing hazardous ozone processes to ensure reliable pharmaceutical intermediate supply.
Patent CN113801859A details high-efficiency carbonyl reductase mutants for chiral alcohol synthesis, offering superior stereoselectivity and cost reduction in pharmaceutical manufacturing.
Patent CN112442474B reveals a robust Fusarium oxysporum lactamase for optically pure (-) gamma-lactam production, offering superior stability and cost-effective manufacturing solutions.
Patent CN115850252A discloses a novel iron-iodine co-catalyzed one-pot synthesis for high-purity pharmaceutical intermediates, offering significant cost reduction and supply chain reliability.
Patent CN101973954A reveals a green, aqueous synthesis route for 3,4-dihydro-1,3-oxazin-2-ones, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN101701027B details a novel catalytic cracking method for nucleosides, offering high-yield production of tetraacetyl ribofuranose and acetylated purines for reliable pharmaceutical intermediates supply chains.
Patent CN113527081B reveals a safer Mitsunobu route for 3-oxocyclobutanecarboxylic acid. Discover cost reduction in pharma intermediate manufacturing and scalable supply solutions.